Memory impairment: FDA reporting patterns
135,721 FDA FAERS reports mention Memory impairment. 74,819 reports have a serious outcome flag.
Medicines named as suspect
- Natalizumab: 7,732 reports
- Interferon Beta-1a: 6,692 reports
- Dimethyl Fumarate: 5,368 reports
- Etanercept: 4,760 reports
- Adalimumab: 4,722 reports
- Pregabalin: 4,003 reports
- Tofacitinib: 3,946 reports
- Valsartan: 3,163 reports
- Fingolimod: 2,948 reports
- Acetaminophen: 2,904 reports
- Oxycodone: 2,711 reports
- Methotrexate: 2,501 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.